Our host, Richard Sokolov, Executive Director and Co-founder of IDE Group, speaks with Sam van Bohemen, Co-founder and CEO of Nuroflux. 

Richard and Sam discuss how Nuroflux is trying to solve the $6 Billion problem with a novel approach, why technology isn’t everything, and what you need as a founder for a successful commercial outcome.

About Sam van Bohemen and Nuroflux
There is a stroke every 19 minutes in Australia, and the associated costs are $6 billion annually just for Australians. Stroke is the second leading cause of death worldwide. Unfortunately, current standard care relies upon subjective observations, and CT perfusion scans do not provide continuous monitoring. However, for an oxygen-starved brain, every second counts.

That is why Sam, founder and CEO of Nuroflux, wants to revolutionise stroke patient care with the first-ever device for continuous, long-term monitoring of brain activity and blood flow in the brain. 

Their solution is a wearable device for real-time monitoring of patients with acute ischaemic stroke. It provides continuous monitoring of blood flow and electrical activity in the brain to allow rapid detection and treatment of complications to improve outcomes and reduce the need for repeat CT scans to lower the radiation risk and financial costs.

Nuroflux was born out of seeing how blind the situation can be around stroke and engineers teaming up with clinicians and commercialisation experts to define, discover and deliver.

Nuroflux is the winner of the BBFH challenge 2021 taking home $25,000 of development and commercialisation support from IDE. They recently formed a strategic partnership with The George Institute for Global Health. 

About the BBFH Series
The Building Better Futures for Health (BBFH) Series is a series of interviews with Founders, Professors, Executives, and other leaders of the Australian start-up community. Together with our guests, we explore and analyse the drivers and challenges of the healthcare start-up community in Australia and discuss their unique journeys and stories. 

Chapters/Timestamps
0:00 Introduction
1:04 Background of Sam
2:32 Why Stroke Care and the jump to commercialisation
4:45 Trying to solve the $6 Billion Dollar problem with a novel approach
7:02 The journey of Nuroflux from Health 10x to pre-seed funding
9:09 Winning the BBFH Challenge
10:20 Next stage of developing the product
11:18 Takeaways from BBFH for a start-up
12:45 What you need as a Medtech founder for a successful commercial outcome
16:23 Why technology isn’t everything
17:50 The goal of improving stroke patient outcome

Website IDE:  https://www.idegroup.com.au/videos-podcasts

Website Nuroflux: https://nuroflux.com/

Website BBFH Challenge: https://www.bbfhchallenge.com/

LinkedIn: https://www.linkedin.com/company/ide-/

Twitter: https://twitter.com/ide_group

Facebook: https://www.facebook.com/IDEGroupAU/

Instagram: https://www.instagram.com/ide.group/

#startups #podcast #bbfh #entrepreneurship #innovationinhealthcare #strokecare #stroke #medtech

Our host, Richard Sokolov, Executive Director and Co-founder of IDE Group, speaks with Sam van Bohemen, Co-founder and CEO of Nuroflux. 
Richard and Sam discuss how Nuroflux is trying to solve the $6 Billion problem with a novel approach, why technology isn’t everything, and what you need as a founder for a successful commercial outcome.
About Sam van Bohemen and Nuroflux There is a stroke every 19 minutes in Australia, and the associated costs are $6 billion annually just for Australians. Stroke is the second leading cause of death worldwide. Unfortunately, current standard care relies upon subjective observations, and CT perfusion scans do not provide continuous monitoring. However, for an oxygen-starved brain, every second counts.
That is why Sam, founder and CEO of Nuroflux, wants to revolutionise stroke patient care with the first-ever device for continuous, long-term monitoring of brain activity and blood flow in the brain. 
Their solution is a wearable device for real-time monitoring of patients with acute ischaemic stroke. It provides continuous monitoring of blood flow and electrical activity in the brain to allow rapid detection and treatment of complications to improve outcomes and reduce the need for repeat CT scans to lower the radiation risk and financial costs.
Nuroflux was born out of seeing how blind the situation can be around stroke and engineers teaming up with clinicians and commercialisation experts to define, discover and deliver.
Nuroflux is the winner of the BBFH challenge 2021 taking home $25,000 of development and commercialisation support from IDE. They recently formed a strategic partnership with The George Institute for Global Health. 
About the BBFH Series The Building Better Futures for Health (BBFH) Series is a series of interviews with Founders, Professors, Executives, and other leaders of the Australian start-up community. Together with our guests, we explore and analyse the drivers and challenges of the healthcare start-up community in Australia and discuss their unique journeys and stories. 
Chapters/Timestamps  0:00 Introduction 1:04 Background of Sam 2:32 Why Stroke Care and the jump to commercialisation 4:45 Trying to solve the $6 Billion Dollar problem with a novel approach 7:02 The journey of Nuroflux from Health 10x to pre-seed funding 9:09 Winning the BBFH Challenge 10:20 Next stage of developing the product 11:18 Takeaways from BBFH for a start-up 12:45 What you need as a Medtech founder for a successful commercial outcome 16:23 Why technology isn’t everything 17:50 The goal of improving stroke patient outcome
Website IDE:  <a href="https://www.idegroup.com.au/videos-podcasts">https://www.idegroup.com.au/videos-podcasts</a>
Website Nuroflux: <a href="https://nuroflux.com/">https://nuroflux.com/</a>
Website BBFH Challenge: <a href="https://www.bbfhchallenge.com/">https://www.bbfhchallenge.com/</a>
LinkedIn: <a href="https://www.linkedin.com/company/ide-/">https://www.linkedin.com/company/ide-/</a>
Twitter: <a href="https://twitter.com/ide_group">https://twitter.com/ide_group</a>  
Facebook: <a href="https://www.facebook.com/IDEGroupAU/">https://www.facebook.com/IDEGroupAU/</a> 
Instagram: <a href="https://www.instagram.com/ide.group/">https://www.instagram.com/ide.group/</a>  
#startups #podcast #bbfh #entrepreneurship #innovationinhealthcare #strokecare #stroke #medtech

The Building Better Futures for Health (BBFH) Series is a series of interviews with founders, professors, executives, and other leaders of the Australian startup community. Together with our guests, we explore and analyse the drivers and challenges of the healthcare startup community in Australia and talk about their unique journeys and stories. 

The Building Better Futures for Health (BBFH) Series is a series of interviews with founders, professors, executives, and other leaders of the Australian startup community. Together with our guests, we explore and analyse the drivers and challenges of the healthcare startup community in Australia and talk about their unique journeys and stories.&nbsp;

Building Better Futures for Health Series

IDE’s BBFH Series, hosted by IDE Group, is a series of interviews with former winners, judges and contestants of the annual Building Better Futures for Health (BBFH) Challenge.

The BBFH Challenge invites entrepreneurs, researchers and industry professionals worldwide to apply and receive up to $30,000 worth of product development, commercialisation and entrepreneurial support from IDE Group, bringing Medtech ideas to life and kick-starting the journey to commercialisation.

BBFH provides finalists and winners with the unique opportunity to obtain advice, mentorship, and financial guidance from IDE and the selected judging panel. Collectively they have access to a cross-functional team of entrepreneurs, scientists, designers, engineers, and clinical professionals, bringing an established network of knowledge, experiences, and connections in the medical technology field.

IDE&rsquo;s BBFH Series, hosted by IDE Group, is a series of interviews with former winners, judges and contestants of the annual Building Better Futures for Health (BBFH) Challenge.
The BBFH Challenge invites entrepreneurs, researchers and industry professionals worldwide to apply and receive up to $30,000 worth of product development, commercialisation and entrepreneurial support from IDE Group, bringing Medtech ideas to life and kick-starting the journey to commercialisation.
BBFH provides finalists and winners with the unique opportunity to obtain advice, mentorship, and financial guidance from IDE and the selected judging panel. Collectively they have access to a cross-functional team of entrepreneurs, scientists, designers, engineers, and clinical professionals, bringing an established network of knowledge, experiences, and connections in the medical technology field.

Advertisement